Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis
LIHC (liver hepatocellular carcinoma) mostly occurs in patients with chronic liver disease. It is primarily induced by a vicious cycle of liver injury, inflammation, and regeneration that usually last for decades. The G protein nucleolar 2 (GNL2), as a protein-encoding gene, is also known as NGP1, N...
Main Authors: | Yiwei Dong, Qianqian Cai, Lisheng Fu, Haojie Liu, Mingzhe Ma, Xingzhong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/4873678 |
Similar Items
-
Application of staining of nucleolar organizer regions of cytological smears of hepatocellular carcinoma and liver diseases
by: Liu Tzu Yin, et al.
Published: (1993) -
Expression of nucleolar spindle-associated protein 1 in hepatocellular carcinoma and its effect on clinical prognosis: A bioinformatics analysis
by: JIN Xinmin
Published: (2021-07-01) -
The potential value of CDV3 in the prognosis evaluation in Hepatocellular carcinoma
by: Heng Xiao, et al.
Published: (2018-06-01) -
Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma
by: Binghua Li, et al.
Published: (2018-07-01) -
Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function
by: Lukas Müller, et al.
Published: (2021-08-01)